ACC 2025 Insights: Cardiac Function, Clinical Outcomes and Effect of…

ACC 2025 Insights

K. Jering

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

How to Make the Diagnosis of ATTR Amyloidosis

Scripps Health

B. Sperry

Transplant in Amyloidosis

Scripps Health

M. Urey

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Using Cardiac MRI to Assess Progression and Treatment Response

The France Foundation

D. Kwon

Cardiomyopathies: 2024 Wrap Up

Cardiology 2024 Year in Review

A. Masri

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran

When to Suspect Amyloidosis

Scripps Health

S. Cuddy

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

CHEST 2023 Insights: Interstitial Lung Abnormality (ILA)

CHEST 2023 Insights

S. Raoof

ACC 2023: Practice-Changing Recommendations from the 2021 Chest Pain…

ACC 2023 Conference Coverage

R. Bullock-Palmer

Cardiac Amyloidosis: Evaluation and New Therapies

Cleveland Clinic Heart, Vascular and Thoracic Institute

M. Hanna

Therapies for Pulmonary Venous Hypertension: Updates on the Treatmen…

Scripps Health

R. Mohan

ACC 2022: Clinical Utility of Myocardial Blood Flow Assessment With …

ACC 2022 Conference Coverage

R. Thompson

Evaluation of Non-Ischemic Dilated Cardiomyopathy: Imaging and Genet…

Houston Methodist DeBakey Heart and Vascular Center

N. Fida